Crohn’s and Colitis Canada is calling on the New Brunswick government to delay, and reconsider, a proposed change to cheaper drug coverage for patients living with inflammatory bowel disease (IBD). The province says the move can be done safely and effectively for about 3,000 arthritis, IBD and psoriasis patients. And while Crohn’s and Colitis Canada admits the risk is low, it says caution is needed. Callum Smith reports.
Reference-globalnews.ca